Combiotic: plant-based antimicrobial and anti-inflammatory respiratory solution

Overview

Combiotic™ is an innovative plant-based solution aimed at supporting upper respiratory health. It combines natural small molecules with inorganic salts to provide antimicrobial and anti-inflammatory effects. Designed for nasal and oral delivery, Combiotic™ offers solutions in the form of a nasal spray, oral softgel, and portable nebulizer, ensuring ease of use and rapid symptom relief. Preclinical studies indicate its potent efficacy against 12 WHO-priority respiratory pathogens, surpassing conventional treatments. The solution is backed by GLP-level biocompatibility, toxicity, and stability data, aligning with OTC regulatory requirements.

Technical specifications

Key features:

• Synergistic combination of plant-based small molecules and inorganic salts
• Available in nasal spray, oral softgel, and nebulizer formats
• Targets sinus-related pathogens, biofilm, and inflammation
• Demonstrates high tolerability and rapid symptom relief
• Supported by third-party GLP-level safety and efficacy data

Applications:

• Chronic sinusitis
• Allergies
• Exposure to airborne pollutants

Technology readiness level

Combiotic™ is currently at Technology Readiness Level 4, having demonstrated efficacy in preclinical settings. The next steps involve formulation optimization, regulatory preparation, and pilot-scale production, with plans to engage potential licensing and commercialization partners.